Related Articles
Spouses Speak Up: The Impact of Mesh Sling Complications on the Patient’s Spouse – A Qualitative Analysis Study – Una Lee, Shreeya Popat & Jennifer Chyu
Shreeya Popat, Jennifer Chyu, and Una Lee discuss the overlooked impact of mesh sling complications on the partners of urologic patients. Their research, focusing on…
Phase 2 Trial: Chemotherapy Plus Immunotherapy Facilitates Bladder Sparing in Muscle-Invasive Bladder Cancer – Matthew Galsky
Ashish Kamat and Matthew Galsky discuss a phase 2 trial on organ sparing for muscle-invasive bladder cancer, published in Nature Medicine. Dr. Galsky highlights the…
Operationalizing and Coordinating Lutetium-177 PSMA Treatment: Roles of a Multidisciplinary Prostate Cancer Team – Kristen Davis & Sarah Yenser Wood
Dan George discusses the collaborative effort in managing PLUVICTO® therapy for prostate cancer with team members Kristen Davis and Sarah Wood. Dr. Davis describes the…
Role of Quantitative Dosimetry “Presentation” – Carlos Uribe
At the 2024 UCSF-UCLA PSMA Conference, Carlos Uribe emphasizes the critical role of dosimetry in enhancing the precision and personalization of radiopharmaceutical therapies (RPTs), detailing…
The Complex Interplay of Factors Driving Prostate Cancer Disparities – Steven Patierno
Steven Patierno delves into his 25-year journey tackling cancer disparities, with a focus on prostate cancer. Beginning in Washington D.C., Dr. Patierno’s work highlighted the…
Advances Bring New Immunotherapy and Targeted Therapy Options for Non-Muscle Invasive Bladder Cancer – Kriti Mittal & Guru Sonpavde
Kriti Mittal and Guru Sonpavde discuss advancements in the treatment of non-muscle invasive bladder cancer. Dr. Mittal highlights the FDA’s 2020 approval of pembrolizumab for…
AUA’s Surgical Guidelines for BPH: From Patient Assessment to Procedure Selection, Journal Club – Rashid Sayyid & Zachary Klaassen
Rashid Sayyid and Zach Klaassen discuss the AUA’s updated guidelines for surgical therapy of BPH-related lower urinary tract symptoms. They recommend surgery for patients with…
Comprehensive Multi-Region Sampling Reveals Extensive Genomic Heterogeneity in Metastatic Prostate Cancer – Alexander Wyatt
Andrea Miyahira and Alex Wyatt discuss a study on de novo metastatic prostate cancer, revealing its genomic complexity through multiregion sampling. Published in Nature Cancer,…
Comparison of 18F-Based PSMA Radiotracers with [68Ga]Ga-PSMA-11 in PET/CT Imaging of Prostate Cancer-a Systematic Review and Meta-Analysis – Beyond the Abstract
prostate cancer, Gallium-68 based radiotracer, [68Ga]Ga-PSMA-11, [18F]PSMA-1007, [18F]DCFPyL, [18F]JK-PSMA-7, [18F]rhPSMA-7, [18F]AlF-PSMA-11, staging of prostate cancer,
Navigating the Nuances: Exploring Imaging Options and Impact to Treatment Strategies in nmCPRC – Ryan Malone
Zach Klaassen and Ryan Malone discuss the management of Nonmetastatic castration-resistant prostate cancer (nmCRPC), focusing on the evolving role of PSMA PET imaging. They highlight…